Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.

作者: M. Loredana Marcovecchio , Barry Widmer , David B. Dunger , R. Neil Dalton

DOI: 10.1042/CS20080079

关键词:

摘要: ADMA (asymmetric dimethylarginine), an endogenous inhibitor of nitric oxide synthase, is considered a major risk factor for cardiovascular disease and progression renal disease. In the present study we aim to investigate effect acute variations in plasma glucose insulin on levels young people with T1D (Type 1 diabetes). Fifteen patients (ten males) T1D, median age 18.3 (13.2–24.4) years, HbA1c (glycated haemoglobin) 9% (6.4–13.6%), underwent overnight (18:00–08:00 hours) variable infusion euglycaemia, followed by hyperinsulinaemic–euglycaemic clamp (08:00–12:00 hours). Blood samples were collected every 15 min determination ADMA, SDMA (symmetric valine, phenylalanine, arginine, creatinine glucose. Insulin assessed 30 min. During period, increased following evening meal. response protein intake there was significant increase phenylalanine creatinine. For remaining part night, progressively decreased reaching 5 mmol/l 04:00 hours. did not change significantly. hyperinsulinaemic clamp, fall observed, from 0.468±0.056 0.364±0.050 μmol/l (P

参考文章(47)
E. B. Marliss, S. Chevalier, R. Gougeon, J. A. Morais, M. Lamarche, O. A. J. Adegoke, G. Wu, Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover Diabetologia. ,vol. 49, pp. 351- 359 ,(2006) , 10.1007/S00125-005-0066-6
Hilde Marie Angell Eid, Torstein Lyberg, Harald Arnesen, Ingebjørg Seljeflot, Insulin and adiponectin inhibit the TNFα-induced ADMA accumulation in human endothelial cells Atherosclerosis. ,vol. 194, pp. e1- e8 ,(2007) , 10.1016/J.ATHEROSCLEROSIS.2006.11.008
Patrick Bulau, Dariusz Zakrzewicz, Kamila Kitowska, Birgit Wardega, Joachim Kreuder, Oliver Eickelberg, Quantitative assessment of arginine methylation in free versus protein-incorporated amino acids in vitro and in vivo using protein hydrolysis and high-performance liquid chromatography. BioTechniques. ,vol. 40, pp. 305- 310 ,(2006) , 10.2144/000112081
Markus C Stühlinger, Fahim Abbasi, James W Chu, Cindy Lamendola, Tracey L McLaughlin, John P Cooke, Gerald M Reaven, Philip S Tsao, Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. ,vol. 287, pp. 1420- 1426 ,(2002) , 10.1001/JAMA.287.11.1420
Michiel PC Siroen, Michiel C Warlé, Tom Teerlink, Robert J Nijveldt, Ernst J Kuipers, Herold J Metselaar, Hugo W Tilanus, Dirk J Kuik, Joost RM van der Sijp, Sybren Meijer, Ben van der Hoven, Paul AM van Leeuwen, None, The transplanted liver graft is capable of clearing asymmetric dimethylarginine. Liver Transplantation. ,vol. 10, pp. 1524- 1530 ,(2004) , 10.1002/LT.20286
Hannu Päivä, Terho Lehtimäki, Juha Laakso, Inkeri Ruokonen, Vappu Rantalaiho, Ole Wirta, Amos Pasternack, Reijo Laaksonen, Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy. Metabolism-clinical and Experimental. ,vol. 52, pp. 303- 307 ,(2003) , 10.1053/META.2003.50048
Cam T.L Tran, James M Leiper, Patrick Vallance, The DDAH/ADMA/NOS pathway Atherosclerosis Supplements. ,vol. 4, pp. 33- 40 ,(2003) , 10.1016/S1567-5688(03)00032-1
Valeria Sorrenti, Francesco Mazza, Agata Campisi, Luca Vanella, Giovanni Volti, Claudia Giacomo, High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells. Current Neurovascular Research. ,vol. 3, pp. 49- 54 ,(2006) , 10.2174/156720206775541778
Michiel P. C. Siroen, Paul A. M. van Leeuwen, Robert J. Nijveldt, Tom Teerlink, Pieter J. Wouters, Greet Van den Berghe, Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Critical Care Medicine. ,vol. 33, pp. 504- 510 ,(2005) , 10.1097/01.CCM.0000155784.59297.50
N Wahbi, Dimethylarginines in chronic renal failure Journal of Clinical Pathology. ,vol. 54, pp. 470- 473 ,(2001) , 10.1136/JCP.54.6.470